PIN20 THE IMPACT OF COST-EFFECTIVENESS OF COUNTRY SPECIFIC APPLICATION-THE CASE OF DROTRECOGIN ALFA (ACTIVATED) IN SEVERE SEPSIS
Nov 1, 2003, 00:00 AM
10.1016/S1098-3015(10)61917-1
https://www.valueinhealthjournal.com/article/S1098-3015(10)61917-1/fulltext
Section Title :
Section Order :
361
First Page :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61917-1&doi=10.1016/S1098-3015(10)61917-1